A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension Interventions: Drug: PF-07868489; Drug: Placebo for PF-07868489 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn How Different Amounts and Forms of the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults
Conditions: Healthy Participants Interventions: Drug: PF-07899895; Drug: Placebo Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
Conditions: SARS-CoV-2 Infection; COVID-19 Interventions: Biological: BNT162b2; Other: Placebo; Biological: Seasonal Inactivated Influenza Vaccine Sponsors: Pfizer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years
Conditions: SARS-CoV-2; COVID-19 Interventions: Biological: COMIRNATY intramuscular injection Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
Conditions: Breast Cancer Interventions: Drug: vepdegestrant; Drug: Samuraciclib Sponsors: Pfizer; Arvinas Estrogen Receptor, Inc.; Carrick Therapeutics Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers
Conditions: Healthy Interventions: Drug: Drug: PF-07817883 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers
Conditions: Healthy Participants Interventions: Biological: mPnC candidate; Biological: mPnC control Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone
Conditions: Pediatric Growth Hormone Deficiency Interventions: Device: Sharps bin to collect used needles/injections Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
ToFAcitinib in Early Active Axial SpondyloarThritis:
Conditions: Axial Spondyloarthritis Interventions: Drug: Tofacitinib 5 MG Sponsors: Charite University, Berlin, Germany; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer
Conditions: Prostate Cancer Interventions: Drug: Relugolix 120 MG [Orgovyx]; Radiation: SBRT standard of care radiotherapy treatment Sponsors: Yale University; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution
October 30, 2023 -- As COVID-19 continues to impact our communities, and winter approaches—bringing with it increases in respiratory infections—it’s important to stay vigilant and up to date on vaccines and to understand how to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 30, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.
Conditions: Healthy Interventions: Drug: Sisunatovir; Drug: Rabeprazole Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
Conditions: Metastatic Colorectal Cancer; CRC; KRAS/NRAS Mutation Interventions: Drug: Onvansertib; Drug: FOLFIRI; Drug: Bevacizumab; Drug: FOLFOX Sponsors: Cardiff Oncology; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
Conditions: Healthy Interventions: Drug: PF-07976016; Drug: Placebo; Drug: Midazolam Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
Conditions: Migraine Interventions: Combination Product: Zavegepant 10 mg; Combination Product: Placebo - Control 1; Combination Product: Placebo - Control 2 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
